Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwan, E. P.
Right arrow Articles by Gaisano, H. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwan, E. P.
Right arrow Articles by Gaisano, H. Y.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 54:2734-2743, 2005
© 2005 by the American Diabetes Association, Inc.

Glucagon-Like Peptide 1 Regulates Sequential and Compound Exocytosis in Pancreatic Islet ß-Cells

Edwin P. Kwan, and Herbert Y. Gaisano

From the Departments of Medicine and Physiology, University of Toronto, Toronto, Ontario, Canada

Glucagon-like peptide 1 (GLP-1) has been postulated to potentiate insulin secretion by cAMP-mediated enhancement of mobilization and priming of secretory granules, but the precise exocytic events are unknown. We used epi-fluorescent microscopy of the fluorescent dye FM1-43, which incorporates into the plasma membrane and the exocytosing secretory granules (appearing as plasma membrane hotspots). KCl evoked exocytosis of 1.8 ± 0.5 hotspots/rat ß-cell at the cell periphery, 82% of which are single transient increases of low amplitudes (151 ± 7%), suggesting single secretory granule exocytosis; and the remaining 18% are stepwise increases in plasma membrane hotspots with higher amplitudes (170 ± 9%), suggesting sequential secretory granule to secretory granule exocytic fusions. Addition of GLP-1 increased the hotspots to 6.0 ± 0.7/ß-cell and exhibited a larger number of stepwise (41%) than transient (10%) increases with higher amplitudes of 259 ± 19 and 278 ± 23%, respectively. More interestingly, GLP-1 also evoked a robust and sustained pattern (49%) with even higher amplitudes of 354 ± 18%, which are likely accelerated sequential secretory granule–secretory granule fusions. Electron microscopy studies collaborated with these imaging results, showing that GLP-1 increased the number of docked secretory granules at the plasma membrane and also increased the number of events showing direct contact of oncoming secretory granules with secretory granules undergoing exocytosis. We conclude that the potentiation of insulin secretion by GLP-1 is contributed by the mobilization of more insulin secretory granules to dock at the plasma membrane and the acceleration of sequential secretory granule–secretory granule fusions.

Address correspondence and reprint requests to Dr. Herbert Y. Gaisano, University of Toronto, 1 Kings College Circle, Room 7226, Toronto, ON, Canada, M5S 1A8. E-mail: herbert.gaisano{at}utoronto.ca

Abbreviations: DGG, docked granule-granule; EGG, exocytosing granule-granule; GLP-1, glucagon-like peptide 1; IBMX, isobutylmethylxanthine


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
L. Shu, N. S. Sauter, F. T. Schulthess, A. V. Matveyenko, J. Oberholzer, and K. Maedler
Transcription Factor 7-Like 2 Regulates {beta}-Cell Survival and Function in Human Pancreatic Islets
Diabetes, March 1, 2008; 57(3): 645 - 653.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. P. Kwan, L. Xie, L. Sheu, T. Ohtsuka, and H. Y. Gaisano
Interaction Between Munc13-1 and RIM Is Critical for Glucagon-Like Peptide-1 Mediated Rescue of Exocytotic Defects in Munc13-1 Deficient Pancreatic {beta}-Cells
Diabetes, October 1, 2007; 56(10): 2579 - 2588.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Liadis, L. Salmena, E. Kwan, P. Tajmir, S. A. Schroer, A. Radziszewska, X. Li, L. Sheu, M. Eweida, S. Xu, et al.
Distinct In Vivo Roles of Caspase-8 in {beta}-Cells in Physiological and Diabetes Models
Diabetes, September 1, 2007; 56(9): 2302 - 2311.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
P. E. MacDonald and P. Rorsman
The Ins and Outs of Secretion from Pancreatic {beta}-Cells: Control of Single-Vesicle Exo- and Endocytosis
Physiology, April 1, 2007; 22(2): 113 - 121.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
M. Campioni, G. Toffolo, L. T. Shuster, F. J. Service, R. A. Rizza, and C. Cobelli
Incretin effect potentiates beta-cell responsivity to glucose as well as to its rate of change: OGTT and matched intravenous study
Am J Physiol Endocrinol Metab, January 1, 2007; 292(1): E54 - E60.
[Abstract] [Full Text] [PDF]

Home page
 PhysiologyHome page
G. A. Rutter and E. V. Hill
Insulin Vesicle Release: Walk, Kiss, Pause ... Then Run
Physiology, June 1, 2006; 21(3): 189 - 196.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. J. Michael, R. A. Ritzel, L. Haataja, and R. H. Chow
Pancreatic {beta}-Cells Secrete Insulin in Fast- and Slow-Release Forms
Diabetes, March 1, 2006; 55(3): 600 - 607.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.